Tag: Hematocrit

According to the World Anti-Doping Agency (WADA), the misuse of erythropoietin (EPO) can increase red blood cell mass, which thickens the blood and leads to a significantly higher risk of deadly diseases like stroke and heart attack. Understanding how much EPO is too much is critical for patients, athletes, and anyone concerned about this powerful hormone's effects.

Postmarketing reports have identified anemia as a potential adverse reaction to fenofibrate, a medication used to manage high cholesterol and triglycerides [1.2.5, 1.3.2]. So, does fenofibrate cause anemia? While mild decreases in hemoglobin and hematocrit can occur, clinically significant anemia is uncommon [1.2.2, 1.5.1].